LONDON — European stock markets started the new trading week on a positive note, following gains in global stocks, as hopes of a Federal Reserve rate cut in December resurfaced.
pan-european Stocks 600 Most major exchanges and sectors were in positive territory, with the index tentatively closing 0.3% higher.
Bayer AG The company rose 10.9% to lead Monday’s gainers after the German pharmaceutical and biotech company reported positive efficacy data in a Phase III trial of the blood thinner Asundexian, a stroke prevention drug.
novo nordiskBy contrast, the drug semaglutide, the active ingredient in the company’s diabetes and obesity drugs Ozempic and Wigovy, missed key targets in a large trial of its Alzheimer’s disease drug candidate, plunging 5.8% on Monday, paring some of its earlier losses.
AstraZeneca Shares rose 0.8% after the London-listed drugmaker said Friday it would invest $2 billion in a biologics manufacturing plant in Frederick, Maryland, as part of a $50 billion expansion in the United States.
European defense stocks fell on Monday as talks continued between the United States and Ukraine to develop a peace plan, as the initial 28-point proposal was seen as largely pro-Russian and requiring significant concessions from Kiev.
line metal Due to a decline of 5%, Lenk down 4.4%, Hensoldt down 4.6%; serve It fell 5.6%. Overall, the Stoxx 600 Aerospace and Defense Index fell to its lowest level since July, closing 2% lower.
The United States announced on Sunday that talks over the weekend, which included Secretary of State Marco Rubio, had made progress but failed to reach an agreement on Ukraine’s security.
In other places, anglo american Down 0.9% due to Australian multinational mining company BHP It has dropped plans to take over its British rival as a last resort.
world stocks
Asia-Pacific markets and U.S. stock futures rose in overnight trading as markets looked to build on a strong rebound that started on Friday after the New York Fed president left the door open to a rate cut in December.
The next FOMC meeting will be held on December 9-10, and the market is currently pricing in a 69.3% chance of a quarter-point rate cut, according to the CME FedWatch tool.
Global markets have been turbulent for weeks as investors question the soaring prices of artificial intelligence technology stocks, which were a big driver of the market’s 2025 rally.
There will be no major data or earnings releases in Europe on Monday, but British investors are gearing up for Wednesday’s autumn budget, with speculation mounting about the depth and breadth of tax increases that Chancellor of the Exchequer Rachel Reeves may announce as she attempts to balance the budget.
